MMP9 and breast cancer: In present analysis, subgroup of multivariate analysis demonstrated that both MMP2 and MMP9 overexpression predicted a significantly shorter OS after adjustment for known prognostic markers including ER, PR, HER2, and other clinicopathological features, indicating that MMP2 and MMP9 were independent predictors for survival of BC patients.